Philip E. V. A. van Kerrebroeck

Suggest Changes
Learn More
INTRODUCTION To examine pooled efficacy data from three, large phase III studies comparing mirabegron (50 and 100 mg) with placebo, and pooled safety data including additional mirabegron 25 mg and(More)